Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan
2005

Coffee and Liver Cancer Risk in Japan

Sample size: 110688 publication Evidence: moderate

Author Information

Author(s): Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, Sakata R, Fujita Y, Ichikawa S, Iwai N, Tamakoshi A

Primary Institution: Tottori University

Hypothesis

Is there a relationship between coffee consumption and mortality from hepatocellular carcinoma (HCC)?

Conclusion

The study found that coffee consumption is associated with a reduced risk of death from HCC.

Supporting Evidence

  • Coffee drinkers had a hazard ratio of 0.50 for HCC mortality compared to non-drinkers.
  • The study included 110,688 participants from the Japan Collaborative Cohort Study.
  • The results were adjusted for various confounding factors including age and smoking.

Takeaway

Drinking coffee might help people live longer if they have liver cancer.

Methodology

Cox proportional hazards model was used to analyze the relationship between coffee consumption and HCC mortality.

Limitations

The absence of serum markers for HCV or HBV infection is a major limitation.

Participant Demographics

Participants were aged 40-79 years, with 46,399 males and 64,289 females.

Statistical Information

P-Value

0.007

Confidence Interval

0.31–0.79

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602737

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication